Axios @axios
Pfizer told the FDA that data from its clinical trials suggests a third shot of its coronavirus vaccine may be necessary six months after the second dose because of waning efficacy. https://t.co/Blv2RzcPGN — PolitiTweet.org
Created
Wed Sep 15 18:43:00 +0000 2021
Likes
122
Retweets
57
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Axios @axios
Pfizer told the FDA that data from its clinical trials suggests a third shot of its coronavirus vaccine may be necessary six months after the second dose because of waning efficacy. https://t.co/Blv2RzcPGN — PolitiTweet.org